Nicholas H Carbonetti1. 1. Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to summarize and discuss recent findings and selected topics of interest in Bordetella pertussis virulence and pathogenesis and treatment of pertussis. It is not intended to cover issues on immune responses to B. pertussis infection or problems with currently used pertussis vaccines. RECENT FINDINGS: Studies on the activities of various B. pertussis virulence factors include the immunomodulatory activities of filamentous hemagglutinin, fimbriae, and adenylate cyclase toxin. Recently emerging B. pertussis strains show evidence of genetic selection for vaccine escape mutants, with changes in vaccine antigen-expressing genes, some of which may have increased the virulence of this pathogen. Severe and fatal pertussis in young infants continues to be a problem, with several studies highlighting predictors of fatality, including the extreme leukocytosis associated with this infection. Treatments for pertussis are extremely limited, though early antibiotic intervention may be beneficial. Neutralizing pertussis toxin activity may be an effective strategy, as well as targeting two host proteins, pendrin and sphingosine-1-phosphate receptors, as novel potential therapeutic interventions. SUMMARY: Pertussis is reemerging as a major public health problem and continued basic research is revealing information on bacterial virulence and disease pathogenesis, as well as potential novel strategies for vaccination and targets for therapeutic intervention.
PURPOSE OF REVIEW: The purpose of this review is to summarize and discuss recent findings and selected topics of interest in Bordetella pertussis virulence and pathogenesis and treatment of pertussis. It is not intended to cover issues on immune responses to B. pertussis infection or problems with currently used pertussis vaccines. RECENT FINDINGS: Studies on the activities of various B. pertussis virulence factors include the immunomodulatory activities of filamentous hemagglutinin, fimbriae, and adenylate cyclase toxin. Recently emerging B. pertussis strains show evidence of genetic selection for vaccine escape mutants, with changes in vaccine antigen-expressing genes, some of which may have increased the virulence of this pathogen. Severe and fatal pertussis in young infants continues to be a problem, with several studies highlighting predictors of fatality, including the extreme leukocytosis associated with this infection. Treatments for pertussis are extremely limited, though early antibiotic intervention may be beneficial. Neutralizing pertussis toxin activity may be an effective strategy, as well as targeting two host proteins, pendrin and sphingosine-1-phosphate receptors, as novel potential therapeutic interventions. SUMMARY: Pertussis is reemerging as a major public health problem and continued basic research is revealing information on bacterial virulence and disease pathogenesis, as well as potential novel strategies for vaccination and targets for therapeutic intervention.
Authors: Katie L Sealey; Simon R Harris; Norman K Fry; Laurence D Hurst; Andrew R Gorringe; Julian Parkhill; Andrew Preston Journal: J Infect Dis Date: 2014-12-08 Impact factor: 5.226
Authors: Janet B Terry; Christopher J Flatley; Debra J van den Berg; Geoffrey G Morgan; Marianne Trent; John A Turahui; Michelle C Greenwood; Paul W Corben; Greg J Bell Journal: Commun Dis Intell Q Rep Date: 2015-03-31
Authors: Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola Journal: Emerg Infect Dis Date: 2009-08 Impact factor: 6.883
Authors: Audrey J King; Tamara van Gorkom; Jeroen L A Pennings; Han G J van der Heide; Qiushui He; Dimitri Diavatopoulos; Kees Heuvelman; Marjolein van Gent; Karin van Leeuwen; Frits R Mooi Journal: BMC Genomics Date: 2008-06-30 Impact factor: 3.969
Authors: Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo Journal: Pediatr Clin North Am Date: 2017-08-18 Impact factor: 3.278
Authors: J L Gutiérrez-Ferman; L Villarreal-Treviño; J M Ramírez-Aranda; A Camacho-Ortiz; M R Ballesteros-Elizondo; M R Moreno-Juárez; S Mendoza-Olazarán; M E de la O Cavazos; J Z Villarreal-Pérez; M A Gómez-Govea; E Garza-González Journal: Epidemiol Infect Date: 2018-08-23 Impact factor: 4.434
Authors: Elise S Hovingh; Marjolein van Gent; Hendrik-Jan Hamstra; Marc Demkes; Frits R Mooi; Elena Pinelli Journal: PLoS One Date: 2017-01-11 Impact factor: 3.240
Authors: Laura Julia Starost; Sascha Karassek; Yasuteru Sano; Takashi Kanda; Kwang Sik Kim; Ulrich Dobrindt; Christian Rüter; Marcus Alexander Schmidt Journal: Toxins (Basel) Date: 2016-10-13 Impact factor: 4.546